Massive Bio and TrialScope Are Providing A Sneak Peek into the Future of Patient Referrals

Patient recruitment is at the core of Massive Bio’s business and we are not only trying to build a company, we are also trying to optimize and influence an industry. I can assure you that we are trying outrageously hard as there are too many uncontrollable issues and too much waste in oncology patient recruitment.

We also partner with like-minded organizations like TrialScope. TrialScope is developing a marketplace for patient recruitment to provide transparency and high quality information on capabilities/performance of the vendors to the Sponsors. We are supporting TrialScope on the development of the oncology vertical in the marketplace. We are trying to improve efficiency and cut waste in the patient recruitment vendor selection and on-boarding as we need to focus on the “actual work” of patient recruitment instead of cumbersome processes. We need Apple like simplicity/elegance, Amazon like responsiveness/scale and NASA like coordination/security to optimize patient recruitment results.

I am very pleased to announce that this Wednesday, Mike Wenger, VP of Patient Engagement TrialScope; Joel Keefe SVP Solutions, Life Sciences Prognos Health; and I (Co-founder and CEO of Massive Bio) will be discussing the new TrialScope Connect marketplace and report on our progress.

  • Date: April 15, 2020
  • Time: 11:00 am EST
  • Click Here for Registration
  •  
    I totally understand that you have busy schedules, but I would appreciate if you can spend a couple of minutes with us. Very much looking forward to the discussion and let’s not allow any force to stop the clinical trial access to cancer patients. Always with the Day 1 spirit!

    Selin Kurnaz, PhD
    Co-founder and CEO

    Massive Bio, Inc.
    90 West St. #12M,
    New York, NY, 10006

    Media Coverage
    Previous reading
    Non Small Cell Lung Cancer MET
    Next reading
    COVID-19: Tips, Statistics, and Everything You Need to Know